Early Intervention Strategies for Lung Cancer

Recruiting N/A Interventional Study
Respiratory Tract Neoplasms Thoracic Neoplasms Neoplasms by Site Neoplasms Lung Diseases Respiratory Tract Diseases Lung Neoplasms
No Placebo Group Every participant receives an active treatment — no one gets a placebo. Healthy Volunteers Welcome You do not need to have the condition being studied to take part.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
40 – 74
Sex
Any
Study type
Interventional
Purpose
Screening
Participants needed
16,000 (estimated)
Sponsor
The First Affiliated Hospital of Guangzhou Medical University · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial

Low-dose CT (LDCT)can detect and treat lung cancer earlier and more quickly, while expanded screening coverage helps reduce the incidence and mortality of respiratory diseases such as lung cancer. This study aims to conduct a single-arm cluster randomized trial of digitally enabled LDCT in Guangzhou to assess its intervention effectiveness and cost-effectiveness.

Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
1.Community Health Service Centers (Cluster Level) 1. Inclusion Criteria The community health service center must be located within one of the 11 districts of Guangzhou. The center must manage a population of over 10,000 elderly individuals. The center should be equipped with at least one CT ma…
Contacts

Jianxing He, MD

86-20-83337792

drjianxing.he@gmail.com

CONTACT